Charles Schwab’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $19.5M | Sell |
903,638
-64,603
| -7% | -$1.4M | ﹤0.01% | 1760 |
|
|
2025
Q4 | $23.1M | Buy |
968,241
+97,091
| +11% | +$1.98M | ﹤0.01% | 1661 |
|
|
2025
Q3 | $11.8M | Buy |
871,150
+94,408
| +12% | +$982K | ﹤0.01% | 2034 |
|
|
2025
Q2 | $6.32M | Buy |
776,742
+62,740
| +9% | +$536K | ﹤0.01% | 2230 |
|
|
2025
Q1 | $5.6M | Buy |
714,002
+134,379
| +23% | +$1.56M | ﹤0.01% | 2222 |
|
|
2024
Q4 | $8.63M | Buy |
579,623
+12,644
| +2% | +$206K | ﹤0.01% | 2079 |
|
|
2024
Q3 | $8.67M | Buy |
566,979
+59,536
| +12% | +$939K | ﹤0.01% | 2097 |
|
|
2024
Q2 | $7.73M | Buy |
507,443
+14,167
| +3% | +$229K | ﹤0.01% | 2156 |
|
|
2024
Q1 | $9.31M | Buy |
493,276
+21,094
| +4% | +$365K | ﹤0.01% | 2021 |
|
|
2023
Q4 | $9.02M | Buy |
472,182
+11,341
| +2% | +$181K | ﹤0.01% | 2042 |
|
|
2023
Q3 | $8.27M | Buy |
460,841
+24,100
| +6% | +$484K | ﹤0.01% | 2009 |
|
|
2023
Q2 | $8.87M | Buy |
436,741
+15,050
| +4% | +$287K | ﹤0.01% | 1961 |
|
|
2023
Q1 | $7.69M | Buy |
421,691
+32,971
| +8% | +$630K | ﹤0.01% | 1994 |
|
|
2022
Q4 | $8.04M | Buy |
388,720
+9,626
| +3% | +$265K | ﹤0.01% | 1979 |
|
|
2022
Q3 | $9.92M | Buy |
379,094
+35,813
| +10% | +$947K | ﹤0.01% | 1836 |
|
|
2022
Q2 | $8.7M | Buy |
343,281
+12,630
| +4% | +$309K | ﹤0.01% | 1911 |
|
|
2022
Q1 | $10.4M | Buy |
330,651
+8,501
| +3% | +$285K | ﹤0.01% | 1933 |
|
|
2021
Q4 | $13M | Sell |
322,150
-33,091
| -9% | -$1.28M | ﹤0.01% | 1862 |
|
|
2021
Q3 | $12.4M | Buy |
355,241
+10,682
| +3% | +$332K | ﹤0.01% | 1884 |
|
|
2021
Q2 | $9.46M | Buy |
344,559
+11,288
| +3% | +$322K | ﹤0.01% | 2034 |
|
|
2021
Q1 | $9.36M | Buy |
333,271
+46,191
| +16% | +$1.61M | ﹤0.01% | 1997 |
|
|
2020
Q4 | $7.45M | Buy |
287,080
+4,107
| +1% | +$99.4K | ﹤0.01% | 2026 |
|
|
2020
Q3 | $4.85M | Buy |
282,973
+26,720
| +10% | +$597K | ﹤0.01% | 2075 |
|
|
2020
Q2 | $6.34M | Buy |
256,253
+60,012
| +31% | +$1.62M | ﹤0.01% | 1908 |
|
|
2020
Q1 | $2.72M | Buy |
196,241
+4,478
| +2% | +$55.7K | ﹤0.01% | 2139 |
|
|
2019
Q4 | $1.94M | Buy |
191,763
+2,078
| +1% | +$17.5K | ﹤0.01% | 2431 |
|
|
2019
Q3 | $1.73M | Buy |
189,685
+92,558
| +95% | +$744K | ﹤0.01% | 2430 |
|
|
2019
Q2 | $773K | Sell |
97,127
-1,609
| -2% | -$16.1K | ﹤0.01% | 2661 |
|
|
2019
Q1 | $1.23M | Buy |
98,736
+4,897
| +5% | +$53.1K | ﹤0.01% | 2490 |
|
|
2018
Q4 | $1.01M | Buy |
93,839
+43,092
| +85% | +$503K | ﹤0.01% | 2536 |
|
|
2018
Q3 | $708K | Buy |
50,747
+10,706
| +27% | +$137K | ﹤0.01% | 2724 |
|
|
2018
Q2 | $491K | Buy |
+40,041
| New | +$628K | ﹤0.01% | 2810 |
|
Other funds holding RCUS
GS
SCM
VPM
VCM
WP
SL